Cargando…
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction
Background Heart failure is a complex cardiovascular disease with a variety of etiologies and heterogeneity. The N-terminal pro-B-type natriuretic peptide (NT-proBNP) value has limited usefulness in diagnosing heart failure with preserved ejection fraction (HFpEF). Aim The aim of the present study...
Autores principales: | Kanukurti, Jyothirmayi, Mohammed, Noorjahan, Sreedevi, N. N., Khan, Siraj Ahmed, Baba, K.S.S. Sai, Bhaskar, M. Vijaya, Satish, O. Sai, Naushad, Shaik Mohammad, Mohan, Iyyapu Krishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466549/ https://www.ncbi.nlm.nih.gov/pubmed/32905127 http://dx.doi.org/10.1055/s-0040-1716608 |
Ejemplares similares
-
Evaluation of Serum Mammaglobin as an Alternative Biomarker in the Diagnosis of Breast Tumors
por: Fatima, Maira, et al.
Publicado: (2022) -
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011) -
Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction
por: Jiang, Jing, et al.
Publicado: (2022) -
Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Lakhani, Ishan, et al.
Publicado: (2019) -
Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Shi, Yujiao, et al.
Publicado: (2022)